Intervening with nanozymes in aging-related diseases: Strategies for restoring mitochondrial function
Fanyong Yan,
No information about this author
Dongyang Liu,
No information about this author
Baoshan Zhao
No information about this author
et al.
Biomaterials Advances,
Journal Year:
2025,
Volume and Issue:
169, P. 214193 - 214193
Published: Jan. 18, 2025
Language: Английский
Use of Nicotinamide Mononucleotide as Non-Natural Cofactor
Catalysts,
Journal Year:
2025,
Volume and Issue:
15(1), P. 37 - 37
Published: Jan. 3, 2025
Nicotinamide
mononucleotide
(NMN)
has
emerged
as
a
promising
non-natural
cofactor
with
significant
potential
to
transform
biocatalysis,
synthetic
biology,
and
therapeutic
applications.
By
modulating
NAD⁺
metabolism,
NMN
offers
unique
advantages
in
enzymatic
reactions,
metabolic
engineering,
regenerative
medicine.
This
review
provides
comprehensive
analysis
of
NMN’s
biochemical
properties,
mechanisms
action,
diverse
Emphasis
is
placed
on
its
role
addressing
challenges
multi-enzyme
cascades,
biofuel
production,
the
synthesis
high-value
chemicals.
The
paper
also
highlights
critical
research
gaps,
including
need
for
scalable
methods,
improved
integration
into
systems,
toxicity
studies
use.
Emerging
technologies
such
AI-driven
enzyme
design
CRISPR-based
genome
engineering
are
discussed
transformative
tools
optimizing
NMN-dependent
pathways.
Furthermore,
synergistic
biology
innovations,
cell-free
systems
dynamic
regulatory
networks,
explored,
paving
way
precise
modular
biotechnological
solutions.
Looking
forward,
versatility
positions
it
pivotal
tool
advancing
sustainable
bioprocessing
precision
Addressing
current
limitations
through
interdisciplinary
approaches
will
enable
redefine
boundaries
innovation.
serves
roadmap
leveraging
across
scientific
industrial
domains.
Language: Английский
The Role of Hypoxia in Longevity
Ayesha Nisar,
No information about this author
Sawar Khan,
No information about this author
Yongzhang Pan
No information about this author
et al.
Aging and Disease,
Journal Year:
2025,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2025
Aging
is
marked
by
a
progressive
decrease
in
physiological
function
and
reserve
capacity,
which
results
increased
susceptibility
to
diseases.
Understanding
the
mechanisms
of
driving
aging
crucial
for
extending
health
span
promoting
human
longevity.
Hypoxia,
reduced
oxygen
availability,
has
emerged
as
promising
area
study
within
research.
This
review
explores
recent
findings
on
potential
restriction
promote
healthy
extend
lifespan.
While
role
hypoxia-inducible
factor
1
(HIF-1)
cellular
responses
hypoxia
well-established,
its
impact
lifespan
remains
complex
context-dependent.
Investigations
invertebrate
models
suggest
HIF-1
longevity,
while
evidence
mammalian
limited.
Hypoxia
extends
independent
dietary
(DR),
known
intervention
underlying
However,
both
DR
converge
common
downstream
effectors,
such
forkhead
box
O
(FOXO)
flavin-containing
monooxygenase
(FMOs)
modulate
Further
work
required
elucidate
molecular
hypoxia-induced
longevity
optimize
clinical
applications.
crosstalk
between
other
longevity-associated
pathways
developing
interventions
enhance
healthspan.
Future
studies
may
uncover
novel
therapeutic
strategies
populations.
Language: Английский